1887

Abstract

Infection with influenza virus strongly predisposes an individual to bacterial superinfection, which is often the significant cause of morbidity and mortality during influenza epidemics. Little is known about the immunomodulating properties of the virus that lead to this phenomenon, but the effect of the viral components on the development of immune dendritic cells (DCs) may prove vital. In this study, activation of and cytokine secretion by bacterial lipopolysaccharide (LPS)-stimulated bone marrow-derived dendritic cells (BMDCs) following treatment with the influenza virus major antigen haemagglutinin (HA) were examined. HA selectively inhibits the release of LPS-induced interleukin 12 (IL12) p70, which is independent of IL10 secretion. Suppression occurs at the transcriptional level, with selective inhibition of p35- and not p40-subunit mRNA expression. The downregulation of IL12 p70 by influenza HA is a novel and unexplored pathway that may be relevant in the predisposition to bacterial superinfection associated with influenza virus infections.

Loading

Article metrics loading...

/content/journal/jgv/10.1099/vir.0.80891-0
2005-07-01
2024-03-28
Loading full text...

Full text loading...

/deliver/fulltext/jgv/86/7/vir861885.html?itemId=/content/journal/jgv/10.1099/vir.0.80891-0&mimeType=html&fmt=ahah

References

  1. Aste-Amezaga M., Ma X., Sartori A., Trinchieri G. 1998; Molecular mechanisms of the induction of IL-12 and its inhibition by IL-10. J Immunol 160:5936–5944
    [Google Scholar]
  2. Beadling C., Slifka M. K. 2004; How do viral infections predispose patients to bacterial infections?. Curr Opin Infect Dis 17:185–191 [CrossRef]
    [Google Scholar]
  3. Brand C. M., Skehel J. J. 1972; Crystalline antigen from the influenza virus envelope. Nat New Biol 238:145–147
    [Google Scholar]
  4. Colamussi M. L., White M. R., Crouch E., Hartshorn K. L. 1999; Influenza A virus accelerates neutrophil apoptosis and markedly potentiates apoptotic effects of bacteria. Blood 93:2395–2403
    [Google Scholar]
  5. Cousens L. P., Orange J. S., Su H. C., Biron C. A. 1997; Interferon- α / β inhibition of interleukin 12 and interferon- γ production in vitro and endogenously during viral infection. Proc Natl Acad Sci U S A 94:634–639 [CrossRef]
    [Google Scholar]
  6. Gillessen S., Carvajal D., Ling P. 7 other authors 1995; Mouse interleukin-12 (IL-12) p40 homodimer: a potent IL-12 antagonist. Eur J Immunol 25:200–206 [CrossRef]
    [Google Scholar]
  7. Glezen W. P. 2004; The changing epidemiology of respiratory syncytial virus and influenza: impetus for new control measures. Pediatr Infect Dis J 23:S202–S206 [CrossRef]
    [Google Scholar]
  8. Grumont R., Hochrein H., O'Keeffe M., Gugasyan R., White C., Caminschi I., Cook W., Gerondakis S. 2001; c-Rel regulates interleukin 12 p70 expression in CD8+ dendritic cells by specifically inducing p35 gene transcription. J Exp Med 194:1021–1032 [CrossRef]
    [Google Scholar]
  9. Hament J.-M., Kimpen J. L. L., Fleer A., Wolfs T. F. W. 1999; Respiratory viral infection predisposing for bacterial disease: a concise review. FEMS Immunol Med Microbiol 26:189–195 [CrossRef]
    [Google Scholar]
  10. Hartshorn K. L., Liou L. S., White M. R., Kazhdan M. M., Tauber J. L., Tauber A. I. 1995; Neutrophil deactivation by influenza A virus. Role of hemagglutinin binding to specific sialic acid-bearing cellular proteins. J Immunol 154:3952–3960
    [Google Scholar]
  11. Heinzel F. P., Hujer A. M., Ahmed F. N., Rerko R. M. 1997; In vivo production and function of IL-12 p40 homodimers. J Immunol 158:4381–4388
    [Google Scholar]
  12. Howlett R. 2004; Infectious disease: past and future of an old foe. Nature 432:817
    [Google Scholar]
  13. Hussell T., Williams A. 2004; Ménage à trois of bacterial and viral pulmonary pathogens delivers coup de grace to the lung. Clin Exp Immunol 137:8–11 [CrossRef]
    [Google Scholar]
  14. Lehmann J., Bellmann S., Werner C., Schröder R., Schütze N., Alber G. 2001; IL-12p40-dependent agonistic effects on the development of protective innate and adaptive immunity against Salmonella Enteritidis. J Immunol 167:5304–5315 [CrossRef]
    [Google Scholar]
  15. LeVine A. M., Koeningsknecht V., Stark J. M. 2001; Decreased pulmonary clearance of S. pneumoniae following influenza A infection in mice. J Virol Methods 94:173–186 [CrossRef]
    [Google Scholar]
  16. Magram J., Connaughton S. E., Warrier R. R. 7 other authors 1996; IL-12-deficient mice are defective in IFN gamma production and type 1 cytokine responses. Immunity 4:471–481 [CrossRef]
    [Google Scholar]
  17. Marcus P. I., Rojek J. M., Sekellick M. J. 2005; Interferon induction and/or production and its suppression by influenza A viruses. J Virol 79:2880–2890 [CrossRef]
    [Google Scholar]
  18. McGuirk P., McCann C., Mills K. H. G. 2002; Pathogen-specific T regulatory 1 cells induced in the respiratory tract by a bacterial molecule that stimulates interleukin 10 production by dendritic cells: a novel strategy for evasion of protective T helper type 1 responses by Bordetella pertussis . J Exp Med 195:221–231 [CrossRef]
    [Google Scholar]
  19. Murphy T. L., Cleveland M. G., Kulesza P., Magram J., Murphy K. M. 1995; Regulation of interleukin 12 p40 expression through an NF- κ B half-site. Mol Cell Biol 15:5258–5267
    [Google Scholar]
  20. O'Garra A. 1998; Cytokines induce the development of functionally heterogeneous T helper cell subsets. Immunity 8:275–283 [CrossRef]
    [Google Scholar]
  21. Okamoto S., Kawabata S., Nakagawa I., Okuno Y., Goto T., Sano K., Hamada S. 2003; Influenza A virus-infected hosts boost an invasive type of Streptococcus pyogenes infection in mice. J Virol 77:4104–4112 [CrossRef]
    [Google Scholar]
  22. Oppmann B., Lesley R., Blom B. 22 other authors 2000; Novel p19 protein engages IL-12p40 to form a cytokine, IL-23, with biological activities similar as well as distinct from IL-12. Immunity 13:715–725 [CrossRef]
    [Google Scholar]
  23. Oxenius A., Karrer U., Zinkernagel R. M., Hengartner H. 1999; IL-12 is not required for induction of type 1 cytokine responses in viral infections. J Immunol 162:965–973
    [Google Scholar]
  24. Pirhonen J., Matikainen S., Julkunen I. 2002; Regulation of virus-induced IL-12 and IL-23 expression in human macrophages. J Immunol 169:5673–5678 [CrossRef]
    [Google Scholar]
  25. Reichert T. A., Simonsen L., Sharma A., Pardo S. A., Fedson D. S., Miller M. A. 2004; Influenza and the winter increase in mortality in the United States, 1959–1999. Am J Epidemiol 160:492–502 [CrossRef]
    [Google Scholar]
  26. Sanford B. A., Ramsay M. A. 1987; Bacterial adherence to the upper respiratory tract of ferrets infected with influenza A virus. Proc Soc Exp Biol Med 185:120–128 [CrossRef]
    [Google Scholar]
  27. Schijns V. E. C. J., Haagmans B. L., Wierda C. M. H., Kruithof B., Heijnen I. A. F. M., Alber G., Horzinek M. C. 1998; Mice lacking IL-12 develop polarized Th1 cells during viral infection. J Immunol 160:3958–3964
    [Google Scholar]
  28. Seki M., Higashiyama Y., Tomono K. 9 other authors 2004; Acute infection with influenza virus enhances susceptibility to fatal pneumonia following Streptococcus pneumoniae infection in mice with chronic pulmonary colonization with Pseudomonas aeruginosa . Clin Exp Immunol 137:35–40 [CrossRef]
    [Google Scholar]
  29. Snijders A., Hilkens C. M., van der Pouw Kraan T. C., Engel M., Aarden L. A., Kapsenberg M. L. 1996; Regulation of bioactive IL-12 production in lipopolysaccharide-stimulated human monocytes is determined by the expression of the p35 subunit. J Immunol 156:1207–1212
    [Google Scholar]
  30. Takase H., Nitanai H., Yamamura E., Otani T. 1999; Facilitated expansion of pneumococcal colonization from the nose to the lower respiratory tract in mice preinfected with influenza virus. Microbiol Immunol 43:905–907 [CrossRef]
    [Google Scholar]
  31. Thompson W. W., Shay D. K., Weintraub E., Brammer L., Bridges C. B., Cox N. J., Fukuda K. 2004; Influenza-associated hospitalizations in the United States. JAMA 292:1333–1340 [CrossRef]
    [Google Scholar]
  32. Trinchieri G. 1998; Interleukin-12: a cytokine at the interface of inflammation and immunity. Adv Immunol 70:83–243
    [Google Scholar]
  33. Xing Z. 2001; Breach of IL-12 monopoly in the initiation of type 1 immunity to intracellular infections: IL-12 is not required. Cell Mol Biol 47:689–694
    [Google Scholar]
http://instance.metastore.ingenta.com/content/journal/jgv/10.1099/vir.0.80891-0
Loading
/content/journal/jgv/10.1099/vir.0.80891-0
Loading

Data & Media loading...

This is a required field
Please enter a valid email address
Approval was a Success
Invalid data
An Error Occurred
Approval was partially successful, following selected items could not be processed due to error